The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-cyclopentyl-10-methyl-3-phenylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione ID: ALA4784295
PubChem CID: 76284418
Max Phase: Preclinical
Molecular Formula: C23H21N3O2
Molecular Weight: 371.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccccc3)c(C3CCCC3)nc21
Standard InChI: InChI=1S/C23H21N3O2/c1-25-18-14-8-7-13-17(18)20(27)19-22(25)24-21(15-9-5-6-10-15)26(23(19)28)16-11-3-2-4-12-16/h2-4,7-8,11-15H,5-6,9-10H2,1H3
Standard InChI Key: MVBSDSAQVLFZKR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
1.0152 -22.1574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0141 -22.9847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7288 -23.3976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7270 -21.7446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4424 -22.1538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4431 -22.9806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1585 -23.3914 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1528 -21.7396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8687 -22.1468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8723 -22.9764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5914 -23.3862 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3073 -22.9676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2996 -22.1349 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5800 -21.7289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1484 -20.9147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5728 -20.9039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0049 -21.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7235 -22.1241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4335 -21.7056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4261 -20.8797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7028 -20.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9957 -20.8951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0262 -23.3793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1185 -24.1990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9266 -24.3647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3339 -23.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7774 -23.0383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1606 -24.2164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 9 1 0
8 15 2 0
14 16 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
12 23 1 0
7 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.44Molecular Weight (Monoisotopic): 371.1634AlogP: 3.90#Rotatable Bonds: 2Polar Surface Area: 56.89Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.47CX LogD: 4.47Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -0.72
References 1. Luderman KD,Jain P,Benjamin Free R,Conroy JL,Aubé J,Sibley DR,Frankowski KJ. (2021) Development of pyrimidone D1 dopamine receptor positive allosteric modulators., 31 [PMID:33221389 ] [10.1016/j.bmcl.2020.127696 ]